Caregiving often begins with quiet concern a parent notices subtle changes, unexplained symptoms, or developmental delays. What follows for many families in Ghana is not immediate clarity, but a prolonged search for answers that stretches across hospitals, specialists, and years.
For caregivers of people living with rare diseases, care becomes constant and consuming. Emotional distress, financial strain, and social isolation accumulate over time.
Yet while attention is often focused on patients, caregivers parents, siblings, and extended family members carry a psychological burden that remains largely invisible.
Alongside them are healthcare professionals who witness this struggle closely. Pediatricians encounter caregivers at the very start of the journey, while clinical psychologists support families as uncertainty deepens. Public health experts warn that without systems to support caregivers and providers alike, the cost of care becomes unsustainable.
The Long Road to a Diagnosis
Dr. Richard Bright Danyoh, a pediatrician at the Korle Bu Teaching Hospital, says delayed diagnosis is one of the most emotionally taxing aspects of rare disease care—for families and clinicians alike.
“Parents are in limbo for a very long time,” he explains. “They begin to lose interest in the health space because they are not given answers. Sometimes even health workers themselves are not too conversant with what may be wrong.”
This uncertainty stretches over months and sometimes years. As investigations stall and symptoms progress, complications set in. In some cases, Dr. Danyoh says, the window for effective medical intervention closes entirely.
“These cruel delays can lead to complications where only rehabilitation becomes an option,” he says. “As a pediatrician, there is an emotional weight that comes with knowing you are unable to offer meaningful help to the child.”
For caregivers, repeated hospital visits become cycles of hope and disappointment. Anxiety deepens as children deteriorate without explanation. Pediatricians often find themselves managing not only the child’s physical symptoms, but also the mounting distress of parents who feel abandoned by the system.
The emotional toll does not end there. When outcomes are poor, the strain intensifies.
“Sometimes, when death occurs, it reduces morale,” Dr. Danyoh admits. “You feel the weight of not having been able to change the course of things.”
Working in a health system without clear rare disease protocols further compounds this strain. Decision-making becomes uncertain, referrals are unclear, and investigations lack structured pathways.
“Support for care and a clear track for investigation is paramount,” he says. “Guidelines can only be produced if we talk about and diagnose these conditions. Until there is a concerted effort with a dedicated team working on rare diseases, policies will be difficult to formulate.”
Despite their low prevalence, Dr. Danyoh emphasizes that rare diseases carry immense significance for the families affected.
“The numbers may be few,” he says, “but they are significant for individual families. And pediatricians must be central to any national effort, along with other health workers.”
Without institutional support, pediatricians are left vulnerable to compassion fatigue and moral distress knowing what should be done, but lacking the tools to do it.
What would make the biggest difference, he says, is not abstract reform but practical change.
“Having support for diagnostics and treatment in Ghana would go a long way,” Dr. Danyohnotes. “We also need to elevate awareness across all levels of healthcare.”
Caregiving in a System Not Built for Rare Diseases
According to Samuel Agyei Waife, a clinical psychologist who works with persons living with rare diseases, Ghana’s healthcare system is ill-equipped to meet the complex realities caregivers face.
“Many rare diseases are challenging. It’s not normal,” he explains. “Our healthcare system is not set up to meet those needs.”
By the time caregivers reach psychological services, many are already experiencing depression, anxiety, trauma, hopelessness, worthlessness, and chronic stress. These struggles are shaped by unanswered questions why the condition occurred, what treatments exist, and what the future holds.
For caregivers, uncertainty becomes a form of chronic psychological exposure.
The Emotional, Social, and Financial Weight of Care
Caregiving extends far beyond hospital visits. Many caregivers abandon employment or reduce work hours. Social lives shrink. Families reorganise daily routines around appointments, medication schedules, and supervision.
“They are concerned about everything,” Waife says, “from treatment and finances to stigma, future childbirth, and whether they can live a normal life.”
Financial strain intensifies emotional distress. Rare disease care often requires multiple specialists physiotherapists, ophthalmologists, dermatologists, nephrologists—most of whom are not covered by insurance.
Over time, caregivers experience burnout not because they are weak, but because care is unrelenting.
When Professionals Become Caregivers Too
While families are primary caregivers, psychologists often become secondary ones. Supporting rare disease families demands extensive time researching unfamiliar conditions, navigating unclear diagnostic pathways, and advocating within fragmented systems.
This gap between ethical responsibility and systemic reality creates moral distress, where professionals are unable to act according to their training. It becomes increasingly difficult to support caregiver wellbeing when core medical needs remain unmet.
Vicarious Trauma in Rare Disease Care
Rare diseases are often chronic and progressive, requiring long-term engagement. Over time, psychologists develop deep relationships with patients and caregivers.
“For rare disease patients, you become part and parcel of their life,” Waife says. “They become your family.”
Witnessing deterioration sometimes rapid and irreversible leaves lasting psychological scars. Waife describes this as vicarious trauma, a hidden occupational risk in rare disease care.
“You are watching them suffer, and you can’t do much,” he says. “It’s traumatizing.”
Why Policy Often Ignores the Human Cost
From a global public health perspective, Dr. Tomia Austin, rare disease educator and public health expert, says this psychological toll is not unique to Ghana but is magnified in countries without national rare disease policies.
“Globally, policies focus on diagnosis, treatment access, and research infrastructure,” she explains. “The emotional labour of providers is often overlooked.”
In higher-resource settings, some protections exist. The European Union encourages National Rare Disease Plans, with countries like France implementing coordinated care networks and multidisciplinary teams. These systems reduce isolation for caregivers and clinicians alike.
However, even in these settings, provider wellbeing is often treated as an afterthought. “There’s still an assumption that clinicians will simply cope,” Dr. Austin says. “Asking for help is still seen as weakness.”
What Best Practice Looks Like Elsewhere
International models show that caregiver and provider wellbeing can be protected when treated as a quality-of-care issue.
In the United Kingdom, structured clinical supervision and reflective practice are embedded in the National Health Service, giving professionals protected time to process emotional strain. Australia’s National Strategic Action Plan for Rare Diseases includes workforce wellbeing strategies such as peer support systems and psychosocial training.
Trauma-informed careused widely in Canada, the United States, and the UK emphasizes provider safety, shared decision-making, and organizational transparency. These frameworks help prevent professionals from internalizing families’ trauma.
“These models recognize that sustainable care depends on protected caregivers and supported providers,” Dr. Austin notes.
Policy Silence and Moral Distress in Ghana
In Ghana, the absence of a national rare disease policy compounds stress for caregivers and clinicians alike.
Dr. Austin describes this as a textbook case of moral distress. Professionals may know what best-practice care looks like but lack the tools to deliver it. Psychologists become emotional anchors for families while witnessing repeated suffering without systemic change.
What Ghana Could Realistically Do
According to Dr. Austin, meaningful change does not require massive investment. Peer supervision networks used in the UK could be implemented virtually. Regional rare disease focal points, as used in Australia, could improve coordination. Simplified referral pathways would reduce uncertainty for caregivers and professionals alike.
Most importantly, a national policy must explicitly protect provider mental health.
“Burnout and secondary trauma should be formally recognized,” Dr. Austin says. “Caseload standards, supervision, debriefing, and counseling access must be part of the policy.”
Who Cares for the Caregivers?
Caregivers remain the invisible backbone of rare disease care in Ghana emotionally exhausted, financially strained, and often unsupported. Pediatricians see their distress first. Psychologists carry it longest. Public health experts warn that without systemic reform, both families and providers will continue to suffer in silence.
Until caregiver wellbeing is recognized as a public health priority and until rare diseases are addressed through a coherent national policy the burden of care will remain personal, uneven, and heavy.
